Antitumor activity of a novel Aurora A/B kinases inhibitor TY-011 against gastric cancer by inducing DNA damage

被引:1
|
作者
Jiang Tongtong [1 ]
Liu Wang [1 ]
Lu Yu [2 ]
Fang Yanfen [1 ]
Chen Rui [1 ]
Zhang Wanli [1 ]
Liu Xuan [3 ]
Zhang Xiongwen [1 ]
机构
[1] East China Normal Univ, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Sch Chem & Mol Engn, Shanghai 200062, Peoples R China
[2] Nanjing Tianyi Biosci Co Ltd, Dept Project Management, Nanjing, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, Shanghai, Peoples R China
关键词
apoptosis; Aurora A; B kinases inhibitor; DNA damage; gastric cancer cells; TY-011; B KINASE; APOPTOSIS;
D O I
10.1097/CAD.0000000000000928
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TY-011, a novel Aurora A/B kinases inhibitor, was found in our previous study to exhibit prominent inhibitory effects on growth of gastric cancer, both in vitro and in vivo. To clarify the mechanisms of TY-011 in inhibiting proliferation of gastric cancer cells, the effects of TY-011 on mitosis, cell cycle, apoptosis and cellular DNA were checked in the present study. Our results showed that TY-011 treatment induced aberrant mitosis, G2/M phase arrest and apoptosis. Importantly, TY-011 induced evident DNA damage in MGC-803 and MKN-45 human gastric cancer cells, which was further characterized as DNA double-strand break. Furthermore, cells treated with TY-011 appeared to generate multiple spindle fibers emanating from several spindle poles, leading to poly-merotelic kinetochore. These results suggested that TY-011 induced abnormal microtubule-kinetochores attachment and thus DNA damage, apoptosis and finally inhibition of cell proliferation of human gastric cancer cells.
引用
收藏
页码:440 / 451
页数:12
相关论文
共 50 条
  • [31] DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer
    Xiang-ling Chen
    Peng Liu
    Wei-liang Zhu
    Li-guang Lou
    Acta Pharmacologica Sinica, 2021, 42 : 132 - 141
  • [32] Activity of the novel Aurora kinase B inhibitor AZD2811 in biomarker-defined models of small cell lung cancer
    Della Corte, C. M.
    Ajpacaja, L.
    Cardnell, R. J.
    Gay, C. M.
    Wang, Q.
    Shen, L.
    Ramkumar, K.
    Stewart, A. C.
    Fan, Y-H.
    Adelman, C. A.
    Travers, J.
    Wang, J.
    Heymach, J.
    Byers, L. A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells
    Jin, Rong
    Xia, Yiqun
    Chen, Qiuxiang
    Li, Wulan
    Chen, Dahui
    Ye, Hui
    Zhao, Chengguang
    Du, Xiaojing
    Shi, Dengjian
    Wu, Jianzhang
    Liang, Guang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 979 - 995
  • [34] Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo
    Yang, Bohan
    Yu, Dandan
    Liu, Jingwen
    Yang, Kunyu
    Wu, Gang
    Liu, Hongli
    TUMOR BIOLOGY, 2015, 36 (07) : 5051 - 5061
  • [35] Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest
    Yu, Lei
    Han, Shuang
    Lang, Lang
    Song, Hui
    Zhang, CaiYun
    Dong, Lin
    Jia, ShaoHua
    Zhang, Ying
    Xiao, Di
    Liu, Jun
    Xu, Ying
    Zhang, XiaoPo
    PHYTOMEDICINE, 2021, 84
  • [36] S39, a novel Aurora B kinase inhibitor, shows potent antineoplastic activity in human Hela cervical cancer cell line
    Li, Jie
    Lang, Qingyu
    Zhang, Haoxing
    Huang, Qiang
    Yu, Long
    BIOTECHNOLOGY LETTERS, 2013, 35 (06) : 853 - 860
  • [37] S39, a novel Aurora B kinase inhibitor, shows potent antineoplastic activity in human Hela cervical cancer cell line
    Jie Li
    Qingyu Lang
    Haoxing Zhang
    Qiang Huang
    Long Yu
    Biotechnology Letters, 2013, 35 : 853 - 860
  • [38] Pazopanib, a Novel Multitargeted Kinase Inhibitor, Shows Potent In Vitro Antitumor Activity in Gastric Cancer Cell Lines with FGFR2 Amplification
    Kim, Seung Tae
    Jang, Hye-Lim
    Lee, Su Jin
    Lee, Jeeyun
    Choi, Yoon-La
    Kim, Kyoung-Mee
    Cho, Jeonghee
    Park, Se Hoon
    Park, Young Suk
    Lim, Ho Yeong
    Yashiro, Masakazu
    Kang, Won Ki
    Park, Joon Oh
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (11) : 2527 - 2536
  • [39] The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models
    Wengner, Antje M.
    Siemeister, Gerhard
    Luecking, Ulrich
    Lefranc, Julien
    Wortmann, Lars
    Lienau, Philip
    Bader, Benjamin
    Boemer, Ulf
    Moosmayer, Dieter
    Eberspaecher, Uwe
    Golfier, Sven
    Schatz, Christoph A.
    Baumgart, Simon J.
    Haendler, Bernard
    Lejeune, Pascale
    Schlicker, Andreas
    von Nussbaum, Franz
    Brands, Michael
    Ziegelbauer, Karl
    Mumberg, Dominik
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (01) : 26 - 38
  • [40] Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer
    Wang, Yuehong
    Wu, Linying
    Yao, Yinan
    Lu, Guohua
    Xu, Liming
    Zhou, Jianying
    CANCER LETTERS, 2018, 436 : 1 - 9